Autonomic nervous system-mediated effects of galanin-like peptide on lipid metabolism in liver and adipose tissue

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Hirako, Satoshi ^a   Wada, Nobuhiro ^b   Kageyama, Haruaki ^c   Takenoya, Fumiko ^d   Izumida, Yoshihiko ^b   Kim, Hyounju ^e   Iizuka, Yuzuru ^e   Matsumoto, Akiyo ^e   Okabe, Mai ^f   Kimura, Ai ^d   Suzuki, Mamiko ^g   Yamanaka, Satoru ^g   Shioda, Seiji ^d  

^a UNIVERSITY OF HUMAN ARTS AND SCIENCES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KIRYU UNIVERSITY   (Japan)

^d HOSHI UNIVERSITY   (Japan)

^e JOSAI UNIVERSITY   (Japan)

^f Tokyo Shokuryo Dietitian Academy   (Japan)

^g SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GALANIN LIKE PEPTIDE; MESSENGER RNA;

ADIPOSE TISSUE; ANIMAL; AUTONOMIC NERVOUS SYSTEM; DIET RESTRICTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INNERVATION; LIPID METABOLISM; LIVER; MALE; METABOLISM; MOUSE; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; AUTONOMIC NERVOUS SYSTEM; FASTING; GALANIN-LIKE PEPTIDE; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIVER; MALE; MICE; RNA, MESSENGER;

EID: 84958999072     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21481     Document Type: Article

References (39)

1. Wilson, P. W., D'Agostino, R. B., Sullivan, L., Parise, H., Kannel, W. B. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch. Intern. Med. 162, 1867-1872 (2002).
2. Meshkani, R., Adeli, K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin. Biochem. 42, 1331-1346 (2009).
3. Kodama, K., Sasaki, H., Shimizu, Y. Trend of coronary heart disease and its relationship to risk factors in a Japanese population: a 26-year follow-up, Hiroshima/Nagasaki study. Jpn Circ.J. 54, 414-421 (1990).
4. Nonogaki, K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43, 533-549 (2000).
5. Shimazu, T. Innervation of the liver and glucoregulation: roles of the hypothalamus and autonomic nerves. Nutrition 12, 65-66 (1996).
6. Perseghin, G. et al. Regulation of glucose homeostasis in humans with denervated livers. J. Clin. Invest. 100, 931-941 (1997).
7. Nonogaki, K., Iguchi, A. Role of central neural mechanisms in the regulation of hepatic glucose metabolism. Life Sci. 60, 797-807 (1997).
8. Bartness, T. J., Bamshad, M. Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am.J. Physiol. 275, R1399-1411 (1998).
9. Lafontan, M., Berlan, M. Fat cell alpha 2-adrenoceptors: the regulation of fat cell function and lipolysis. Endocr. Rev. 16, 716-738 (1995).
10. Lafontan, M., Langin, D. Lipolysis and lipid mobilization in human adipose tissue. Prog. Lipid. Res. 48, 275-297 (2009).
11. Ahmadian, M., Wang, Y., Sul, H. S. Lipolysis in adipocytes. Int. J. Biochem. Cell. Biol. 42, 555-559 (2010).
12. Izumida, Y. et al. Glycogen shortage during fasting triggers liver-brain-adipose neurocircuitry to facilitate fat utilization. Nat. Commun. 4, 2316 (2013).
13. Uno, K. et al. Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 312, 1656-1659 (2006).
14. Tsukita, S. et al. Hepatic glucokinase modulates obesity predisposition by regulating BAT thermogenesis via neural signals. Cell. Metab. 16, 825-832 (2012).
15. Ohtaki, T. et al. Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus. J. Biol. Chem. 274, 37041-37045 (1999).
16. Takenoya, F. et al. Galanin-like peptide is target for regulation by orexin in the rat hypothalamus. Neurosci. Lett. 340, 209-212 (2003).
17. Takenoya, F. et al. Galanin-like peptide is co-localized with alpha-melanocyte stimulating hormone but not with neuropeptide Y in the rat brain. Neurosci. Lett. 331, 119-122 (2002).
18. Takenoya, F. et al. Neuronal interactions between galanin-like-peptide-and orexin-or melanin-concentrating hormone-containing neurons. Regul. Pept. 126, 79-83 (2005).
19. Man, P. S., Lawrence, C. B. The effects of galanin-like peptide on energy balance, body temperature and brain activity in the mouse and rat are independent of the GALR2/3 receptor. J. Neuroendocrinol. 20, 128-137 (2008).
20. Krasnow, S. M. et al. A role for galanin-like peptide in the integration of feeding, body weight regulation, and reproduction in the mouse. Endocrinology 144, 813-822 (2003).
21. Krasnow, S. M. et al. Analysis of the contribution of galanin receptors 1 and 2 to the central actions of galanin-like peptide. Neuroendocrinology 79, 268-277 (2004).
22. Kauffman, A. S., Buenzle, J., Fraley G. S., Rissman, E. F. Effects of galanin-like peptide (GALP) on locomotion, reproduction, and body weight in female and male mice. Horm. Behav. 48, 141-151 (2005).
23. Takatsu, Y. et al. Distribution of galanin-like peptide in the rat brain. Endocrinology 142, 1626-1634 (2001).
24. Hansen, K. R. et al. Activation of the sympathetic nervous system by galanin-like peptide-a possible link between leptin and metabolism. Endocrinology 144, 4709-4717 (2003).
25. Lawrence, C. B., Baudoin, F. M., Luckman, S. M. Centrally administered galanin-like peptide modifies food intake in the rat: a comparison with galanin. J. Neuroendocrinol. 14, 853-860 (2002).
26. Ito, K. et al. Interactive effect of galanin-like peptide (GALP) and spontaneous exercise on energy metabolism. Peptides 49, 109-116 (2013).
27. Palou, M. et al. Sequential changes in the expression of genes involved in lipid metabolism in adipose tissue and liver in response to fasting. Pflugers. Arch. 456, 825-836 (2008).
28. Ikeda, I. et al. Impact of fasting time on hepatic lipid metabolism in nutritional animal studies. Biosci. Biotechnol. Biochem. 78, 1584-1591 (2014).
29. Wang, Y. X. PPARs: diverse regulators in energy metabolism and metabolic diseases. Cell Res. 20, 124-137 (2010).
30. Kersten, S. et al. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103, 1489-1498 (1999).
31. Leone, T. C., Weinheimer, C. J., Kelly, D. P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA. 96, 7473-7478 (1999).
32. Miyamoto, L. et al. Leptin activates hepatic 5?-AMP-activated protein kinase through sympathetic nervous system and alpha1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin. J. Biol. Chem. 287, 40441-40447 (2012).
33. Tanida, M., Yamamoto, N., Shibamoto, T., Rahmouni, K. Involvement of hypothalamic AMP-activated protein kinase in leptininduced sympathetic nerve activation. PloS one 8, e56660 (2013).
34. Minokoshi, Y. et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343 (2002).
35. Kageyama, H. et al. Galanin-like peptide (GALP) facilitates thermogenesis via synthesis of prostaglandin E2 by astrocytes in the periventricular zone of the third ventricle. J. Mol. Neurosci. 50, 443-452 (2013).
36. Potthoff, M. J. et al. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc. Natl. Acad. Sci. USA. 106, 10853-10858 (2009).
37. Lundasen, T. et al. PPARalpha is a key regulator of hepatic FGF21. Biochem. Biophys. Res. Commun. 360, 437-440 (2007).
38. Folch, J., Lees, M., Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497-509 (1957).
39. Hirano, M. et al. New protein extraction/solubilization protocol for gel-based proteomics of rat (female) whole brain and brain regions. Mol. Cells. 22, 119-125 (2006).